How long has vertex been in business?
Isabella Turner
Updated on January 20, 2026
1989
Vertex Pharmaceuticals
| Type | Public |
|---|---|
| Traded as | Nasdaq: VRTX NASDAQ-100 component S&P 500 component |
| Industry | Pharmaceuticals & Biotherapeutics |
| Founded | 1989 |
| Headquarters | Boston, Massachusetts |
What type of company is vertex?
global biotechnology company
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases.
What happened to Vertex Pharmaceuticals?
[Updated: 6/15/2021] VRTX Stock Decline The stock price of Vertex Pharmaceuticals (NASDAQ: VRTX) has seen an 8.1% drop over the last five trading days, after the company announced that it will discontinue the clinical trials for VX-864, an experimental treatment for the rare genetic disorder alpha-1 antitrypsin.
Why is Vertex Pharmaceuticals stock going down?
Vertex Pharmaceuticals (VRTX) – Get Report shares fell on Friday after the company nixed a closely watched effort to develop a therapy for a rare genetic disorder that affects the lungs and liver, though analysts took the price drop as reason to potentially jump in.
How many employees does Vertex have?
3,000
Vertex Pharmaceuticals/Number of employees
Who founded Vertex?
Joshua Boger
Vertex Pharmaceuticals/Founders
Dr. Joshua Boger is the founder of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX). He retired as Vertex’s Chief Executive Officer in May 2009, after over 20-years with the company.
How many employees are in a vertex?
How much cash does Vertex have?
Compare VRTX With Other Stocks
| Vertex Pharmaceuticals Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2020 | $6,659 |
| 2019 | $3,808 |
| 2018 | $3,168 |
| 2017 | $2,089 |
Will Vertex stock recover?
Recovery ahead Shares of Vertex aren’t going to recover their recent losses overnight, but this company’s position in cystic fibrosis appears safe from any competitive threats for the foreseeable future.
What drugs does vertex make?
KALYDECO®, the KALYDECO logo, ORKAMBI®, the ORKAMBI logo, SYMDEKO®, the SYMDEKO logo, TRIKAFTA®, and the TRIKAFTA logo, Vertex and the Vertex triangle logo are registered trademarks of Vertex Pharmaceuticals Incorporated.
How old was vertex when it was founded?
Vertex was founded over 30 years ago, with the keen sense that transformational technologies would be a critical differentiator in an increasingly competitive world.
Where are the headquarters of Vertex Pharmaceuticals located?
Vertex Pharmaceuticals. It maintains headquarters in South Boston, Massachusetts, and two research facilities, in San Diego, California, and Oxford, England. The company’s beginnings were profiled by Barry Werth in the 1994 book The Billion-Dollar Molecule and its further development in his 2014 book, The Antidote: Inside the World of New Pharma.
What kind of companies does Vertex Ventures invest in?
Vertex Ventures SEA & India invested in Grab, a technology company that ride hailing, food delivery and payment solutions through its intelligent online and smartphone platform. Vertex Ventures US invested in Desktop Metal, a technology company that is accelerating the transformation of manufacturing with end-to-end metal 3D printing solutions.
What kind of diseases does Vertex Pharmaceuticals treat?
The company’s beginnings were profiled by Barry Werth in the 1994 book, The Billion-Dollar Molecule and it’s further developed in his 2014 book, The Antidote: Inside the World of New Pharma. By 2004, its product pipeline focused on viral infections, inflammatory and autoimmune disorders, and cancer.
